53 related articles for article (PubMed ID: 18494612)
1. Clinical and pathological observation of conversion therapy for malignant peritoneal mesothelioma: a case report and literature review.
Deng M; Zhang X; Xu C; Luo R; Chen L; Zhou Y; Hou Y
Pathol Oncol Res; 2023; 29():1611577. PubMed ID: 38273860
[No Abstract] [Full Text] [Related]
2. Primary intrahepatic mesotheliomas: A case presentation and literature review.
Ismael H; Cox S
Int J Surg Case Rep; 2018; 47():1-6. PubMed ID: 29698884
[TBL] [Abstract][Full Text] [Related]
3. A case of multiple primary malignancies including peritoneal mesothelioma surviving over 11 years.
Esmati E; Rezaei S; Jafari F
Clin Case Rep; 2021 May; 9(5):e04096. PubMed ID: 34026139
[TBL] [Abstract][Full Text] [Related]
4. Mesothelioma in children.
Wassermann M; Wassermann D; Steinitz R; Katz L; Lemesch C
IARC Sci Publ; 1980; (30):253-7. PubMed ID: 7239644
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of diffuse malignant peritoneal mesothelioma.
Hung YP; Dong F; Torre M; Crum CP; Bueno R; Chirieac LR
Mod Pathol; 2020 Nov; 33(11):2269-2279. PubMed ID: 32504035
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic and genetic characteristics of young patients with pleural diffuse malignant mesothelioma.
Vivero M; Bueno R; Chirieac LR
Mod Pathol; 2018 Jan; 31(1):122-131. PubMed ID: 28884745
[TBL] [Abstract][Full Text] [Related]
7. Imaging of the pediatric peritoneum, mesentery and omentum.
Dillman JR; Smith EA; Morani AC; Trout AT
Pediatr Radiol; 2017 Jul; 47(8):987-1000. PubMed ID: 28646385
[TBL] [Abstract][Full Text] [Related]
8. Keratin 5 overexpression is associated with serous ovarian cancer recurrence and chemotherapy resistance.
Ricciardelli C; Lokman NA; Pyragius CE; Ween MP; Macpherson AM; Ruszkiewicz A; Hoffmann P; Oehler MK
Oncotarget; 2017 Mar; 8(11):17819-17832. PubMed ID: 28147318
[TBL] [Abstract][Full Text] [Related]
9. [Medical insurance aspects of peritoneal tumors with particular attention to peritoneal mesotheliomas].
Neumann V; Löseke S; Tannapfel A
Med Klin (Munich); 2009 Oct; 104(10):765-71. PubMed ID: 19856150
[TBL] [Abstract][Full Text] [Related]
10. What are the current best immunohistochemical markers for the diagnosis of epithelioid mesothelioma? A review and update.
Ordóñez NG
Hum Pathol; 2007 Jan; 38(1):1-16. PubMed ID: 17056092
[TBL] [Abstract][Full Text] [Related]
11. Value of immunohistochemistry in distinguishing peritoneal mesothelioma from serous carcinoma of the ovary and peritoneum: a review and update.
Ordóñez NG
Adv Anat Pathol; 2006 Jan; 13(1):16-25. PubMed ID: 16462153
[TBL] [Abstract][Full Text] [Related]
12. Primary peritoneal mesotheliomas in children: a clinicopathological and immunohistochemical study of eight cases.
Moran CA; Albores-Saavedra J; Suster S
Histopathology; 2008 Jun; 52(7):824-30. PubMed ID: 18494612
[TBL] [Abstract][Full Text] [Related]
13. Well-differentiated papillary mesothelioma of the female peritoneum: a clinicopathologic study of 26 cases.
Malpica A; Sant'Ambrogio S; Deavers MT; Silva EG
Am J Surg Pathol; 2012 Jan; 36(1):117-27. PubMed ID: 22024662
[TBL] [Abstract][Full Text] [Related]
14. The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions.
Shield PW; Koivurinne K
Cytopathology; 2008 Aug; 19(4):218-23. PubMed ID: 17916095
[TBL] [Abstract][Full Text] [Related]
15. Diffuse malignant epithelial mesotheliomas of the peritoneum in women: a clinicopathologic study of 25 patients.
Kerrigan SA; Turnnir RT; Clement PB; Young RH; Churg A
Cancer; 2002 Jan; 94(2):378-85. PubMed ID: 11905410
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
